KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Gains from Investment Securities: 2010-2024

Historic Gains from Investment Securities for Dynavax Technologies (DVAX) over the last 12 years, with Dec 2024 value amounting to $925,000.

  • Dynavax Technologies' Gains from Investment Securities was N/A to $925,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.6 million, marking a year-over-year change of. This contributed to the annual value of $925,000 for FY2024, which is 90.86% down from last year.
  • As of Q4 2024, Dynavax Technologies' Gains from Investment Securities stood at $925,000, which was down 91.81% from $11.3 million recorded in Q1 2024.
  • Dynavax Technologies' 5-year Gains from Investment Securities high stood at $45.1 million for Q3 2021, and its period low was -$21.2 million during Q3 2020.
  • Its 3-year average for Gains from Investment Securities is $5.2 million, with a median of $1.0 million in 2022.
  • Per our database at Business Quant, Dynavax Technologies' Gains from Investment Securities plummeted by 2,484.40% in 2020 and then spiked by 3,962.59% in 2024.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Gains from Investment Securities stood at -$21.2 million in 2020, then spiked by 312.38% to -$19.2 million in 2021, then soared by 101.94% to $373,000 in 2022, then slumped by 97.68% to $10.4 million in 2023, then soared by 3,962.59% to $925,000 in 2024.
  • Its Gains from Investment Securities stands at $925,000 for Q4 2024, versus $11.3 million for Q1 2024 and $10.4 million for Q3 2023.